All Articles

Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a

Emerging role of MYB transcription factors in cancer drug resistance

HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs

The therapeutic potential of circular RNA in triple-negative breast cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer

Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications

Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia

Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors

Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia

Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer

Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel

Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers

Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Autophagy-related mechanisms for treatment of multiple myeloma